Search

Your search keyword '"McLean, Huong Q"' showing total 493 results

Search Constraints

Start Over You searched for: Author "McLean, Huong Q" Remove constraint Author: "McLean, Huong Q"
493 results on '"McLean, Huong Q"'

Search Results

1. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022

2. Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes

7. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020

8. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals.

10. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals

12. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019

14. Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness-- Wisconsin, October 2022-February 2023

16. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.

17. Work Attendance during Acute Respiratory Illness Before and During the COVID-19 Pandemic, United States, 2018-2022

18. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States

19. Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016

31. Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink

34. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015

40. Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022

41. Household Transmission of Influenza A Viruses in 2021-2022

42. The Impact of Household Physical Distancing and its Timing on the Transmission of Sars-Cov-2: Insights from a Household Transmission Study

45. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States

46. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness--United States, February 2022

48. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season

49. Burden of medically attended influenza infection and cases averted by vaccination – United States, 2016/17 through 2018/19 influenza seasons

50. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season

Catalog

Books, media, physical & digital resources